Close Menu

Tekmira Pharmaceuticals this week said that it has completed the main part of a phase I study of the siRNA-based cancer drug TKM-PLK1, and is slated to present the trial’s results in two weeks at the American Association for Cancer Research’s annual meeting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.